EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® and QARZIBA®▼ in Greater China
January 13, 2020 07:00 ET
|
BeiGene, LTD.
- SYLVANT® and QARZIBA®▼ recently listed for fast-track approval in China – - Expands EUSA’s global product offering; broadens BeiGene’s portfolio – HEMEL HEMPSTEAD, England and CAMBRIDGE, Mass. and...
Emergent BioSolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast
January 13, 2020 06:30 ET
|
Emergent BioSolutions
Full year 2019 preliminary revenues and adjusted profitability metrics in line with prior guidanceFull year 2020 forecast reflects continued growth of core business as well as investments in key...
BeiGene to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 08, 2020 07:30 ET
|
BeiGene, LTD.
CAMBRIDGE, Mass. and BEIJING, China, Jan. 08, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...
ObsEva SA to Participate in in JP Morgan Healthcare Conference January 13-16, 2020
January 07, 2020 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – January 7, 2020 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s...
Emergent BioSolutions to Participate in Investor Conferences
January 06, 2020 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
Emergent BioSolutions Announces Preliminary 2018 Financial Results and Provides 2019 Financial Forecast
January 07, 2019 06:30 ET
|
Emergent BioSolutions
Full year 2018 preliminary performance in line with recently revised guidanceFull year 2019 forecast reflects continued growth of organic business and anticipated positive impact of recent...
ObsEva SA to Participate in JP Morgan Healthcare Conference January 7-10, 2019
January 02, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston – January 2, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2019 in San Francisco
December 27, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
DXC Technology, EY, Ford Motor Company, JP Morgan Chase & Co., Microsoft, and SAP launch the “Autism @ Work Employer Roundtable”
October 23, 2017 09:00 ET
|
USBLN - US Business Leadership Network
Washington D.C., Oct. 23, 2017 (GLOBE NEWSWIRE) -- US Business Leadership Network (USBLN) along with: DXC Technology, EY, Ford Motor Company, JP Morgan Chase & Co., Microsoft, and SAP have...